Cheap pharmacy drugs spread sheet frequency waves lift - pharmacy, generic drugs - the pharmaceutical industry
-Made generic drugs and original research and technology in the process no different from most. It stands to reason, foreign drug patent expired drugs, and domestic prices of generic drugs should be the same. Which is not the case, the government pricing policies for foreign-funded enterprises are domestic enterprises known as "super-national treatment", and grievances inevitably.
87 times the spread Box of the treatment of primary hypertension valsartan capsules origin of Hainan Macao, the United States and China-made generic drugs as long as 24.6 yuan, while foreign origin Beijing Novartis drug has to 39.7 yuan, a difference of 15.1 yuan. This is the 7 November, people in Guangdong's large pharmacy offer "more than one drug," the price difference in the table to see an example. Form of similar foreign-made drugs and drugs commonly spreads to 2 / 3.
Jiangxi Yick Fung Dispensary in a similar form previously provided, the foreign price gap between the drugs and medicines are made more than 6 to 8 times in between. Captopril Tablets which American Shanghai Squibb production price is 148 yuan, Changzhou, prices of pharmaceutical production in the same packaging as long as 3.4 yuan, the spread 87 times, even more staggering.
Recent travels uproar against the "American SmithKline cheap pharmacy blocking" of the Guangdong people Dispensary Jiang Xin, general manager told reporters the foreign drugs and the huge price difference between domestic drugs, that foreign investment and joint ventures in drug prices There should be a lot of water. And that is generic with the same specifications and components of foreign drug prices are generally higher than domestic drug you 1 / 3 to 2 / 3, including some commonly used drugs. Minister of Supply and Marketing
the pharmacy Qian Cheng also told reporters: "Some of the new drug after the patent expired, it should gradually with the average price of generic drugs the same as R & D costs and the profits should have been back in the early period to the patent medicine the. but the fact is that many foreign drugs after patents are still held up 'patent medicine', 'original study drug' brand, which is very reasonable, direct costs of raising a patient buys the medicine. "
Cheng Qian also briefed reporters about the pharmacy being the "conscience and sell drugs?? Similar goods at lower prices" campaign, said the move meant more to consumers right to know, give consumers a clearer comparison brand , and prices, squeezing out the joint venture of drugs, "the price of water."
Special historical background "In fact, China-made generic drugs in the original research process and the most technically no difference. It stands to reason, foreign patent expired drugs, and domestic prices of generic drugs should be the same. The fact, for a foreign government pricing policy is known as the domestic companies 'super-national treatment', and grievances inevitably. "Chinese Medicine & Health Products Marketing Association and Secretary General of living when interviewed disclosed.
According to report, present in most countries, patent medicines and drugs were divided into two kinds of generic drugs. But since the reform and opening up, in order to attract skilled foreign investment, in patent medicines and generic drugs among the original study has added a drug that is has been the patent protection period, all production by the patent medicines available in the market enjoy all the preferential policies; other companies producing similar drugs to generic drugs, does not enjoy any privileges. In other countries, patent protection has been any production of generic drugs are in the market equally.
"If new medicines, the price will certainly be a little higher." Deputy general manager of Shanghai Roche Pharmaceuticals Wang Xinguang recent interview admitted: "Roche's pricing strategy is global, and global ex-factory price agreement . But because different parts of the market system. so finally to the hands of the consumer price differences do exist. "
He analyzed that the prices of foreign drugs, including drugs themselves increase the import prices of all related costs after the landing, plus a special policy environment in Mainland China, the hospital's operating costs are often 50% of the required supplies from the drug. Meanwhile, although the state allows major hospitals pharmaceutical price increases after the tendering of uniform 15% sold, but the reality is usually a higher rate. These factors have caused the same medicine sold in Hong Kong if the 1,000 yuan / box, in the Mainland may have to sell 1600-1700 yuan / box.
Source in the hospital Fortunately, a drug for more than the market price difference gap status, the state also paid special attention. SFDA published in "drugs and labeling regulations manual Decree No. 24" (hereinafter referred to as "Decree 24"), the required October 1, 2007, the replacement of all pharmaceutical packaging, highlighting common name, weakening the trade name. To reduce drug prices. Identify similar drugs on people, compared to the benefits of greater price difference. Cheng Qian
but told reporters that the lack of pharmacological knowledge as ordinary consumers, the brand has many years of drug consumption in mind customer base, and the company has done in hospitals, comprehensive "activities." So the consumer to influence customer choice, to guide rational consumer, I am afraid the time being, the microscopic short-term effect.
We are high quality suppliers, our products such as slitting line , China roll forming machine for oversee buyer. To know more, please visits forming machine.
